Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification, formation, and occurrence of perlolyrine: A β-carboline alkaloid with a furan moiety in foods

  • Herraiz Tomico, Tomás
  • Peña, Adriana
  • Salgado, Antonio
β-Carbolines are naturally occurring bioactive alkaloids found in foods and in vivo. This research reports the identification, characterization, mechanism of formation, and occurrence of perlolyrine (1-(5-(hydroxymethyl)furan-2-yl)-9H-pyrido[3,4-b]indole), a β-carboline with a furan moiety. Perlolyrine did not arise from l-tryptophan and hydroxymethylfurfural but from the reaction of l-tryptophan with 3-deoxyglucosone, an intermediate of carbohydrate degradation. The mechanism of formation occurs through 3,4-dihydro-β-carboline-3-carboxylic acid intermediates (imines), followed by the oxidation of C1′-OH to ketoimine and oxidative decarboxylation at C-3, along with dehydration and cyclization to afford the β-carboline with a furan moiety. The formation of perlolyrine was favored in acidic conditions and temperatures in the range of 70–110 °C. Perlolyrine occurred in the reactions of tryptophan with carbohydrates. The formation rate from fructose was much higher than from glucose. Sucrose also gave perlolyrine under acidic conditions and heating. Perlolyrine was identified in many foods by HPLC-MS and analyzed by HPLC-fluorescence. It occurred in many processed foods such as tomato products including tomato puree, fried tomato, ketchups, tomato juices, and jams but also in soy sauce, beer, balsamic vinegar, fruit juices, dried fruits, fried onion, and honey. The concentrations ranged from an undetected amount to 3.5 μg/g with the highest average levels found in tomato concentrate (1.9 μg/g) and soy sauce (1.5 μg/mL). The results show that perlolyrine formed during the heating process of foods. It is concluded that perlolyrine is widely present in foods and it is daily ingested in the diet., The authors thank Spanish Government-Feder (projects PDC2022-133269-I00 and PID2021-127833OB-I00) and CSIC (200470E658). A.P. thanks Comunidad de Madrid (CAM) and Fondo Social Europeo-Iniciativa de Empleo Juvenil (YEI) for a Garantia Juvenil contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and biophysical and biological studies of N-phenylbenzamide derivatives targeting kinetoplastid parasites

  • Nué Martínez, J. Jonathan
  • Cisneros, David
  • Moreno-Blázquez, María del Valle
  • Fonseca-Berzal, Cristina
  • Manzano, José Ignacio
  • Kraeutler, Damien
  • Ungogo, Marzuq A.
  • Aloraini, Maha A.
  • Elati, Hamza A. A.
  • Ibáñez-Escribano, Alexandra
  • Lagartera, Laura
  • Herraiz Tomico, Tomás
  • Gamarro, Francisco
  • Koning, Harry P. de
  • Gómez-Barrio, Alicia
  • Dardonville, Christophe
The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three series of analogues of the known antiprotozoal kDNA binder 2-((4-(4-((4,5-dihydro-1H-imidazol-3-ium-2-yl)amino)benzamido)phenyl)amino)-4,5-dihydro-1H-imidazol-3-ium (1a). Bis(2-aminoimidazolines) (1) and bis(2-aminobenzimidazoles) (2) showed micromolar range activity against Trypanosoma brucei, whereas bisarylimidamides (3) were submicromolar inhibitors of T. brucei, Trypanosoma cruzi, and Leishmania donovani. None of the compounds showed relevant activity against the urogenital, nonkinetoplastid parasite Trichomonas vaginalis. We show that series 1 and 3 bind strongly and selectively to the minor groove of AT DNA, whereas series 2 also binds by intercalation. The measured pKa indicated different ionization states at pH 7.4, which correlated with the DNA binding affinities (ΔTm) for series 2 and 3. Compound 3a, which was active and selective against the three parasites and displayed adequate metabolic stability, is a fine candidate for in vivo studies., This study was funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) through the projects RTI2018–093940–B-I00 (C.D.) and RTI2018–097210–B–I00 (F.G.) (Co-funded by the European Regional Development Fund. ERDF, “A way to build Europe”), and PDC2022–133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). M.A.U. was funded by a studentship from the Petroleum Technology Development Fund, Abuja, Nigeria. H.A.A.E. is supported by a PhD studentship from the Libyan Government and M.A.A. by a PhD studentship from the Saudi Arabian Ministry of Education., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Formation, identification, and occurrence of the furan-containing β-carboline flazin derived from l-tryptophan and carbohydrates

  • Herraiz Tomico, Tomás
  • Salgado, Antonio
β-Carbolines (βCs) are bioactive indole alkaloids found in foods and in vivo. This work describes the identification, formation, and occurrence in foods of the βC with a furan moiety flazin (1-[5-(hydroxymethyl)furan-2-yl]-9H-pyrido[3,4-b]indole-3-carboxylic acid). Flazin was formed by the reaction of l-tryptophan with 3-deoxyglucosone but not with 5-hydroxymethylfurfural. Its formation was favored in acidic conditions and heating (70–110 °C). The proposed mechanism of formation occurs through the formation of intermediates 3,4-dihydro-β-carboline-3-carboxylic acid (imines), followed by the oxidation to C═O in the carbohydrate chain and aromatization to βC ring with subsequent dehydration steps and cyclization to afford the furan moiety. Flazin is generated in the reactions of tryptophan with carbohydrates. Its formation from fructose was higher than from glucose, whereas sucrose gave flazin under acidic conditions and heating owing to hydrolysis. Flazin was identified in foods by HPLC-MS, and its content was determined by HPLC-fluorescence. It occurred in numerous processed foods, such as tomato products, including crushed tomato puree, fried tomato, ketchup, tomato juices, and jams, but also in soy sauce, beer, balsamic vinegar, fruit juices, dried fruits, fried onions, and honey. Their concentrations ranged from not detected to 22.3 μg/mL, with the highest mean levels found in tomato concentrate (13.9 μg/g) and soy sauce (9.4 μg/mL). Flazin was formed during the heating process, as shown in fresh tomato juice and crushed tomatoes. These results indicate that flazin is widely present in foods and is daily uptaken in the diet., The authors thank the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) for funding through the projects PID2021-127833OB-I00 (co-funded by the European Regional Development Fund, ERDF, “A way to build Europe”), and PDC2022-133269-I00 and PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NexGenerationEU). The authors thank Adriana Peña (AP) and Haroll Mateo Feliz (HMF) for HPLC analyses and Laura Peláez (IQM-CSIC) for HPLC-MS analyses. AP and HMF were recipients of the Garantía Juvenil contract (Comunidad de Madrid and Fondo Social Europeo-YEI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs

  • Nué Martínez, J. Jonathan
  • Maturana, M.
  • Lagartera, Laura
  • Rodríguez-Gutiérrez, J. A.
  • Boer, R.
  • Campos, J. L.
  • Saperas, N.
  • Dardonville, Christophe
High mobility group (HMG) proteins are intrinsically disordered nuclear non-histone chromosomal proteins that play an essential role in many biological processes by regulating the expression of numerous genes in eukaryote cells. HMGA proteins contain three DNA binding motifs, the “AT-hooks”, that bind preferentially to AT-rich sequences in the minor groove of B-form DNA. Understanding the interactions of AT-hook domains with DNA is very relevant from a medical point of view because HMGA proteins are involved in different conditions including cancer and parasitic diseases. We present here the first crystal structure (1.40 Å resolution) of the HMGA AT-hook 1 domain, bound to the minor groove of AT-rich DNA. In contrast to AT-hook 3 which bends DNA and shows a larger minor groove widening, AT-hook 1 binds neighbouring DNA molecules and displays moderate widening of DNA upon binding. The binding affinity and thermodynamics of binding were studied in solution with surface plasmon resonance (SPR)-biosensor and isothermal titration calorimetry (ITC) experiments. AT-hook 1 forms an entropy-driven 2:1 complex with (TTAA)-containing DNA with relatively slow kinetics of association/dissociation. We show that N-phenylbenzamide-derived antikinetoplastid compounds (1–3) bind strongly and specifically to the minor groove of AT-DNA and compete with AT-hook 1 for binding. The central core of the molecule is the basis for the observed sequence selectivity of these compounds. These findings provide clues regarding a possible mode of action of DNA minor groove binding compounds that are relevant to major neglected tropical diseases such as leishmaniasis and trypanosomiasis., This study was funded by Generalitat de Catalunya (Grant: 2021SGR-01042) and by Agencia Estatal de Inves- tigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Un- ion”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, PID2022-140302OB-I00, and PD- C2022−133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(pyridine-2-carboxamidine) DNA Minor Groove Binder Active against Leishmania

  • Nué Martínez, J. Jonathan
  • Leo-Barriga, Marta
  • Herranz, Fernando
  • Koutsogiannis, Zisis
  • Denny, Paul W.
  • Ebiloma, Godwin U.
  • Dardonville, Christophe
  • González-Paredes, Ana
Two types of nanostructured lipid carrier (NLC) formulations of the antileishmanial DNA minor groove binding compound 4-(picolinimidamido)-N-(4-(picolinimidamido)phenyl)benzamide (1) were synthesized by the microemulsion method to evaluate their potential as a delivery system to intracellular forms of the Leishmania parasite. Compound 1-loaded NLC formulations, functionalized with folic acid (FA) or not, showed good colloidal stability both during storage and after dilution in biologically relevant media. The drug release, which was not pH dependent, occurred efficiently at 37 °C. Compound 1 and its NLC formulations displayed a good selectivity index (SI > 40) and were active in the submicromolar range against promastigotes and metacyclic promastigotes of Leishmania major and in the low micromolar range (∼2 μM) against intramacrophage amastigotes. However, they were inactive against Leishmania mexicana. This proof-of-concept study showed that compound 1 could be loaded effectively in NLC and FA-coated NLC whose size and anionic nature (i.e., FA-NLC) are favorable for uptake into macrophages. NLC functionalization with FA had a beneficial effect on the antileishmanial activity of 1 compared with noncoated NLC formulations, which resulted in an increase in selectivity toward the parasite., This study was supported by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Union”, under grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU) and Comunidad de Madrid (Spain) under “Atracción de Talento (Modalidad 1)” program (Reference 2019-T1/IND-12906)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification, occurrence, and mechanism of formation of 1-acetyl-β-carbolines derived from l-tryptophan and methylglyoxal

  • Herraiz Tomico, Tomás
  • Salgado, Antonio
  • Peña, Adriana
β-Carbolines (βCs) are bioactive compounds present in foods and biological systems. This work describes the identification, occurrence, and mechanism of formation of 1-acetyl-β-carbolines (1-acetyl-βCs) that result from the reaction of l-tryptophan with the α-dicarbonyl compound methylglyoxal. Two β-carbolines are characterized as 1-acetyl-β-carboline (AβC) and 1-acetyl-β-carboline-3-carboxylic acid (AβC-COOH). Their formation was favored in acidic conditions and with increasing temperature, but 1-acetyl-βCs also formed in moderate temperatures and in a wide range of pH, including physiological conditions, and in human serum. The formation mechanism relies on tautomerism and cyclization to give 1-(1-hydroxyethyl)-3,4-dihydro-β-carboline-3-carboxylic acid intermediates followed by the oxidation of C1'-OH and aromatization to 1-acetyl-βCs. The formation of 1-acetyl-βCs took place in the reactions of fructose or glucose with tryptophan under heating and depended on the methylglyoxal released during carbohydrate degradation. Formation from carbohydrates increased at neutral or basic pH values as more methylglyoxal was released under those conditions. Thus, 1-acetyl-βCs could be advanced glycation end-products (AGEs). 1-Acetyl-βCs were identified and quantified for the first time in many foods. AβC ranged from undetectable to 250 ng/g with the highest amount detected in honey, bread, cookies, soy sauce, and coffee. On average, AβC-COOH generally appeared in lower concentrations than AβC but it ranged from undetectable to 323 ng/g with the highest levels found in soy sauce, honey, cookies, and fried bread. These results indicate that 1-acetyl-βCs could be relevant βCs in foods and in vivo., The authors thank the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) for funding through the projects PID2021-127833OB-I00 (cofunded by the European Regional Development Fund (ERDF), “A way to build Europe”), and PDC2022-133269-I00 and PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NextGenerationEU). The authors thank Laura Peláez (IQM-CSIC) for HPLC–MS analyses. AP was a recipient of a Garantía Juvenil contract (Comunidad de Madrid and Fondo Social Europeo-YEI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Uncovering the Unusual Inhibition Mechanism of a Trypanosome Alternative Oxidase Inhibitor Displaying Broad-Spectrum Activity against African Animal Trypanosomes

  • Ebiloma, Godwin U.
  • Balogun, Emmanuel O.
  • Arai, Natsumi
  • Otani, Momoka
  • Baldassarri, Cecilia
  • Alhejely, Amani
  • Cueto-Díaz, Eduardo J.
  • De Koning, Harry P.
  • Dardonville, Christophe
  • Shiba, Tomoo
The glucose-dependent respiration of bloodstream forms of the parasite Trypanosoma brucei depends on an unusual and essential mitochondrial electron-transport system, consisting of glycerol-3-phosphate dehydrogenase and the trypanosome alternative oxidase (TAO). We report here the discovery of an allosteric inhibitor of TAO that displays highly potent activity (EC50 values in the range 1-20 nM) against the important veterinary pathogens T. b. brucei, Trypanosoma evansi, Trypanosoma equiperdum, and Trypanosoma congolense, i.e., >5-fold greater potency than the standard drugs. The methylene-linked 2-methyl-4-hydroxybenzoate 2-pyridinyldiphenylphosphonium derivative (1) was the best inhibitor of recombinant TAO (IC50 = 1.3 nM) via a noncompetitive/allosteric mechanism (Ki = 3.46 nM). Remarkably, X-ray crystallography showed that 1 was bound to a site of TAO ∼25 Å from the catalytic pocket. Although 1 demonstrated good safety toward mammalian cells in vitro (selectivity index >2300), it did not fully clear parasitemia in experimental animals, attributable to a high hepatic clearance., This study received funding from the Japan Society for the Promotion of Science (JSPS) through a JSPS postdoctoral fellowship research grant (17F17420), and a Royal Society Grant (RGS\R2\222269) to G.U.E. The research is also funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/ 501100011033), and “ERDF A way of making Europe”, by the “European Union”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGener- ationEU). E.O.B. is a recipient of an Emerging Global Leader (K43) Award and is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW012015. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies

  • Laguna, Almudena
  • Martínez Alonso, Borja
  • Guarnizo Herrero, Víctor
  • Nué Martínez, J. Jonathan
  • Dardonville, Christophe
  • Torrado-Santiago, Santiago
  • Torrado Salmerón, Carlos
[Background/Objectives] Currently there are very few effective oral antileishmanial treatments. In this study we evaluated a new bis(pyridine-2-carboxamidine) antileishmanial drug (JNII40_base) and its hydrochloride salt (JNII40_HCl)., [Methods] The characterization studies performed allowed us to determine the crystallinity, hydration water, and presence of hydrogen bonds in these drugs. Different dissolution methods were employed to predict intestinal absorption. A high-performance liquid chromatography–mass spectrophotometry (HPLC-MS/MS) method was developed for the determination of JNII40 in plasma., [Results] Pharmacokinetic studies in rats of JNII40_base at 100 and 20 mg/kg, and JNII40_HCl at 20 mg/kg, showed a non-linear pharmacokinetic at high doses. An innovative biorelevant medium of phosphate buffer pH 6.8 with polysorbate 80 at 0.6% (w/v) showed high concentration values for JNII40_base at 30 min, which predicts good intestinal absorption. These results were consistent with the bioavailability data, which exhibited a significant (p < 0.05) increase in maximum plasma concentration (Cmax) and a slight delay in time to maximum (Tmax) compared to JNII40_HCl. Furthermore, the sustained release of JNII40_base in this biorelevant media was related to high plasma concentration values at 24 h (C24h) observed in bioavailability studies. These plasma concentrations of JNII40_base were above the half-maximal inhibitory concentration (IC50) against promastigote and amastigote forms of Leishmania donovani, which is indicative of effectiveness and should reduce the occurrence of drug resistance during treatments., [Conclusions] The bioavailability and pharmacokinetic data support the consideration of this drug for further in vivo studies as an oral antileishmanial treatment., This research was funded by the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033), grant numbers PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU) and PID2022-136438OB-I00 (co-funded by the European Regional Development Fund, ERDF, “A way to build Europe”), and by the Complutense University of Madrid (Research Group 910939)., Peer reviewed
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Development and characterization of a new oral antileishmanial bis(pyridine-2-carboxamidine) drug through innovative dissolution testing in biorelevant media combined with pharmacokinetic studies

  • Laguna, Almudena
  • Martínez Alonso, Borja
  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Nué Martinez, J. Jonathan
  • Dardonville, Christophe
  • Torrado Durán, Santiago
  • Torrado Salmerón, Carlos Félix
Background/Objectives: Currently there are very few effective oral antileishmanial treatments. In this study we evaluated a new bis(pyridine-2-carboxamidine) antileishmanial drug (JNII40_base) and its hydrochloride salt (JNII40_HCl). Methods: The characterization studies performed allowed us to determine the crystallinity, hydration water, and presence of hydrogen bonds in these drugs. Different dissolution methods were employed to predict intestinal absorption. A high-performance liquid chromatography–mass spectrophotometry (HPLC-MS/MS) method was developed for the determination of JNII40 in plasma. Results: Pharmacokinetic studies in rats of JNII40_base at 100 and 20 mg/kg, and JNII40_HCl at 20 mg/kg, showed a non-linear pharmacokinetic at high doses. An innovative biorelevant medium of phosphate buffer pH 6.8 with polysorbate 80 at 0.6% (w/v) showed high concentration values for JNII40_base at 30 min, which predicts good intestinal absorption. These results were consistent with the bioavailability data, which exhibited a significant (p < 0.05) increase in maximum plasma concentration (Cmax) and a slight delay in time to maximum (Tmax) compared to JNII40_HCl. Furthermore, the sustained release of JNII40_base in this biorelevant media was related to high plasma concentration values at 24 h (C24h) observed in bioavailability studies. These plasma concentrations of JNII40_base were above the half-maximal inhibitory concentration (IC50) against promastigote and amastigote forms of Leishmania donovani, which is indicative of effectiveness and should reduce the occurrence of drug resistance during treatments. Conclusions: The bioavailability and pharmacokinetic data support the consideration of this drug for further in vivo studies as an oral antileishmanial treatment., Agencia Estatal de Investigación
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Development of chitosan/sodium carboxymethylcellulose complexes to improve the simvastatin release rate: polymer/polymer and drug/polymer interactions' effects on kinetic models

  • López-Manzanara Pérez, Celia
  • Torres Pabón, Norma Sofía|||0000-0002-0028-0802
  • Laguna, Almudena
  • Torrado Durán, Guillermo|||0000-0002-8865-2083
  • Torre Iglesias, Paloma de la
  • Torrado Durán, Santiago
  • Torrado Salmerón, Carlos Félix
16 p., Simvastatin (SIM) is a potent lipid-lowering drug used to control hyper-cholesterolemia and prevent cardiovascular diseases. SIM presents low oral bioavailability (5%) because of its low aqueous solubility. In this work, polyelectrolyte complexes (PEC) are developed with different chitosan (CS) and carboxymethylcellulose (CMC) ratios that will allow for an increase in the SIM dissolution rate (2.54-fold) in simulated intestinal medium (pH 4.5). Scanning Electron Microscopy (SEM) images revealed highly porous structures. The changes between both complexes, PEC-SIM:CS:CMC (1:1:2) and (1:2:1), were related to the relaxation of the polymer chains upon absorption of the dissolution medium. Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and powder X-ray diffraction (XRPD) studies were used to evaluate the polymer/polymer and drug/polymer interactions on the different PEC-SIM:CS:CMC ratios. In addition, the PECSIM: CS:CMC (1:2:1) complex exhibited a high ratio of protonated amino groups (NH3 +) and an increase in intramolecular hydrogen bonds, which were correlated with a high expansion of the interpolymer chains and an increase in the SIM dissolution rate. Different kinetic models such as zero-order, first-order, Higuchi and Korsmeyer?Peppas were studied to evaluate the influence of CS/CMC ionic interactions on the ability to improve the release rate of poorly soluble drugs, Agencia Estatal de Investigación